H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 59 Citations 14,636 116 World Ranking 5864 National Ranking 2756

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Cancer

Mark L. Kahn mainly investigates Cell biology, Receptor, Platelet, Molecular biology and Platelet activation. His Cell biology study combines topics in areas such as PDPN, Podoplanin, Immunology, Endothelium and Protease-activated receptor. The study incorporates disciplines such as Endothelial stem cell and Signal transduction in addition to Receptor.

His work in GPVI and Platelet membrane glycoprotein are all subfields of Platelet research. His study in the fields of Convulxin under the domain of GPVI overlaps with other disciplines such as Linker for Activation of T cells. His Molecular biology research is multidisciplinary, relying on both Secretion, A549 cell, Gene expression and Transfection.

His most cited work include:

  • A dual thrombin receptor system for platelet activation (873 citations)
  • Protease-activated receptor 3 is a second thrombin receptor in humans. (790 citations)
  • Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin (691 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Cell biology, Platelet, Receptor, GPVI and Signal transduction. The concepts of his Cell biology study are interwoven with issues in Endothelial stem cell, Biochemistry, Lymphatic system and Protease-activated receptor, Thrombin. Mark L. Kahn has researched Protease-activated receptor in several fields, including Inflammation and Thrombin receptor.

His Platelet research includes themes of Collagen receptor and Integrin. His GPVI research is multidisciplinary, incorporating elements of Immune receptor, Calmodulin and Fc receptor. His studies deal with areas such as Function and Phosphorylation as well as Signal transduction.

He most often published in these fields:

  • Cell biology (47.53%)
  • Platelet (35.80%)
  • Receptor (27.16%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cell biology (47.53%)
  • Lymphatic system (17.90%)
  • Pathology (13.58%)

In recent papers he was focusing on the following fields of study:

Mark L. Kahn focuses on Cell biology, Lymphatic system, Pathology, Cancer research and Transcription factor. His work carried out in the field of Cell biology brings together such families of science as Receptor, Stimulation and FOXC2. While the research belongs to areas of Receptor, Mark L. Kahn spends his time largely on the problem of Zebrafish, intersecting his research to questions surrounding CXCR4 and Chemokine.

His Lymphatic system study combines topics in areas such as Endothelial stem cell, Vascular endothelial growth factor C, Lung and Lymphangiogenesis. His biological study spans a wide range of topics, including Hemostasis, Wound healing and Platelet activation, Platelet, Thrombin. His Pathology study combines topics from a wide range of disciplines, such as Cerebral cavernous malformations, Lung injury, Immune system and Mutation.

Between 2017 and 2021, his most popular works were:

  • Mechanically activated ion channel PIEZO1 is required for lymphatic valve formation (76 citations)
  • Neutrophil accumulation and NET release contribute to thrombosis in HIT (50 citations)
  • Lymphatic impairment leads to pulmonary tertiary lymphoid organ formation and alveolar damage (22 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Cancer

Mark L. Kahn mainly focuses on Pathology, Cell biology, Lymphatic system, Protein kinase A and Lymph. His studies in Pathology integrate themes in fields like Mutation and Familial cerebral cavernous malformation. His research in Cell biology is mostly concerned with Hippo signaling pathway.

The Lymphatic system study combines topics in areas such as Hennekam syndrome, Lung injury and Cell polarity. His study in Protein kinase A is interdisciplinary in nature, drawing from both Lesion, Myosin light-chain kinase, Hindbrain, Somatic cell and Phenotype. His study in the field of Lymphatic Endothelium also crosses realms of PIEZO1.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A dual thrombin receptor system for platelet activation

Mark L. Kahn;Yao-Wu Zheng;Wei Huang;Violeta Bigornia.
Nature (1998)

1186 Citations

Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin

Mark L. Kahn;Mayumi Nakanishi-Matsui;Michael J. Shapiro;Hiroaki Ishihara.
Journal of Clinical Investigation (1999)

1082 Citations

Protease-activated receptor 3 is a second thrombin receptor in humans.

Hiroaki Ishihara;Andrew J. Connolly;Dewan Zeng;Mark L. Kahn.
Nature (1997)

1036 Citations

Role of the thrombin receptor in development and evidence for a second receptor

Andrew J. Connolly;Hiroaki Ishihara;Mark L. Kahn;Robert V. Farese.
Nature (1996)

593 Citations

Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2

Stephan K. Böhm;Wuyi Kong;Dieter Brömme;Steven P. Smeekens.
Biochemical Journal (1996)

537 Citations

Regulation of Blood and Lymphatic Vascular Separation by Signaling Proteins SLP-76 and Syk

Farhad Abtahian;Anastasia Guerriero;Eric Sebzda;Min-Min Lu.
Science (2003)

499 Citations

Platelets regulate lymphatic vascular development through CLEC-2–SLP-76 signaling

Cara C. Bertozzi;Alec A. Schmaier;Patricia Mericko;Paul R. Hess.
Blood (2010)

408 Citations

Delayed Onset of Inflammation in Protease-Activated Receptor-2-Deficient Mice

Jonathan R. Lindner;Mark L. Kahn;Shaun R. Coughlin;Gilberto R. Sambrano.
Journal of Immunology (2000)

324 Citations

Klf2 Is an Essential Regulator of Vascular Hemodynamic Forces In Vivo

John S. Lee;Qing Yu;Jordan T. Shin;Eric Sebzda.
Developmental Cell (2006)

275 Citations

Protease activated receptors: theme and variations.

Peter J O'Brien;Marina Molino;Mark Kahn;Lawrence F Brass.
Oncogene (2001)

274 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Mark L. Kahn

Steve P. Watson

Steve P. Watson

University of Birmingham

Publications: 113

Morley D. Hollenberg

Morley D. Hollenberg

University of Calgary

Publications: 108

Bernhard Nieswandt

Bernhard Nieswandt

University of Würzburg

Publications: 77

Elizabeth E. Gardiner

Elizabeth E. Gardiner

Australian National University

Publications: 72

Nigel W. Bunnett

Nigel W. Bunnett

Columbia University

Publications: 57

Shaun R. Coughlin

Shaun R. Coughlin

University of California, San Francisco

Publications: 52

Nathalie Vergnolle

Nathalie Vergnolle

Digestive Health Research Institute

Publications: 51

Martine Jandrot-Perrus

Martine Jandrot-Perrus

Université Paris Cité

Publications: 43

Wolfram Ruf

Wolfram Ruf

Johannes Gutenberg University of Mainz

Publications: 43

Scott L. Diamond

Scott L. Diamond

University of Pennsylvania

Publications: 42

Michael C. Berndt

Michael C. Berndt

Curtin University

Publications: 41

Satya P. Kunapuli

Satya P. Kunapuli

Temple University

Publications: 40

Nigel Mackman

Nigel Mackman

University of North Carolina at Chapel Hill

Publications: 35

Lawrence F. Brass

Lawrence F. Brass

University of Pennsylvania

Publications: 34

Lijun Xia

Lijun Xia

Oklahoma Medical Research Foundation

Publications: 33

Shaun P. Jackson

Shaun P. Jackson

University of Sydney

Publications: 32

Something went wrong. Please try again later.